ZyCal Bioceuticals, Inc. is an is an innovative, employee-owned, green company that specializes in manufacturing and marketing supplements that work at the molecular level. We are committed to providing superior products and services to healthcare providers and their patients, as well as directly to consumers who are seeking a better quality of life.
Our state-of the art, FDA registered, GMP-certified, non-GMO, BSE-free production process strictly adheres to the fundamental principles of manufacturing excellence and the highest standards of quality control that is typically only seen in pharmaceutical-grade manufacturing.
We make it our goal to employ American workers, and our business supports the small, natural cattle ranchers in Wisconsin and the central plains.
Our flagship product is Ostinol®, which is a breakthrough in nutrigenomic nutrition. Ostinol® is powered by a biologically active protein complex that is extracted from certified-organic bovine (cow) bones. Ostinol® is the first biologically active nutritional supplement that activates bone and joint stem cells to help the body naturally grow new, healthy bone and cartilage tissue.
Ostinol® also helps maintain healthy inflammatory responses for optimal bone and joint comfort.
This amazing supplement has been shown to provide benefits in as little as 7 days!
While Ostinol® is a revolutionary product, its active ingredient — a powerful protein complex — is not new. Through research since its discovery in 1965, this protein complex has been proven to be capable of stimulating the formation of new bone and cartilage tissue. So far, it’s had a 50-year evolution of scientific and medical research and more than 25 years of successful use in orthopedic surgery recovery.
Though Ostinol® is ZyCal’s flagship product, the company also offers other products that contain its biologically active protein complex ingredient.
- Chondrinol® is a joint support supplement that combines this active ingredient with Glucosamine and Chondroitin to create a trifecta in joint health, function, and comfort.
- Gastrotene™ is a gastrointestinal support supplement that contains biologically active nutrients combined with Glutamine and Slippery Elm for optimal digestion, nourishment, and function.
At ZyCal Bioceuticals, Inc., we are dedicated to manufacturing and marketing products that enhance the body’s natural ability to safely maintain proper health. We provide superior products for people of all ages and offer services that enrich – and even change – people’s lives.
People are at the core of all we do, and we offer supplements that improve people’s quality of life. We also help healthcare providers deliver better patient care. In addition, we provide our direct-buy customers with the time and attention they deserve to help them make the best personal choices about our health-boosting products. Our invaluable employees make it possible for us to do it all.
We understand, appreciate, and recognize the significant contributions that our employees make every day. Therefore, we strive to provide support and opportunities to help our employees be happy at work and to grow professionally.
We also care about our community and various populations of people-in-need. We regularly contribute to worthy causes with our time, talents, and financial resources, and we make a dedicated effort to spread the joy of hope in our acts of philanthropy.
Our main goal is to create a better quality of life for as many people as possible through our products, passions, and provisions.
THE MANAGEMENT TEAM
ZyCal Bioceuticals, Inc.’s Executive Management Team has broad management experience with a concentration in healthcare. The Management Team has brought strategic thought leadership to such companies as Procter & Gamble, Johnson & Johnson, Morgan Stanley, and PricewaterhouseCoopers. Members of the Management Team have successfully launched start-up businesses prior to forming ZyCal Bioceuticals, Inc.
Chairman of the Board
Chairing the Board of Directors is Mr. James Hobbs, currently President of Athro Kinetics Inc. and managing partner of Graylyn Associates. Mr. Hobbs’s twenty-five years of executive management experience includes; CEO of Endospine Kinetics (acquired), CEO of Luxtec Corp. (acquired) and CEO of Genica Pharmaceuticals (acquired). Additionally, Mr. Hobbs served as President of Johnson & Johnson Professional Diagnostics, a division of J&J.
JAMES J. SCAFFIDI
CEO, President, and Executive Director
Mr. Scaffidi founded ZyCal in February 2006 after working in the healthcare industry for nearly 20 years. He has managed several business units, and has experience in sales, sales management, marketing, operations and product launches with Procter & Gamble as well as other biotechnology, diagnostic, and orthopedics companies. Mr. Scaffidi has been involved with and responsible for numerous product launches, strategic marketing, business development planning, and repositioning flagship brands for successful growth. His ability to foster clear strategic visions, communicate plans and execute strategies, has led to successful new product launches, capitalization on new business opportunities and reversal of flat and declining brands into fortunes. Mr. Scaffidi received his BS degree from City University of New York in Biochemistry and completed three years of research in enzymology and protein purification.
DANIEL TRIPODI, PHD
Chief Scientific Officer
Dr. Tripodi has served a variety of biomedical and biopharmaceutical companies in the areas of R&D, Marketing, and Technological and Strategic Planning. Most of Dr. Tripodi’s industrial career was with Johnson & Johnson. During his approximately 20 years there, he held various senior positions at both the divisional and corporate levels. He was instrumental in establishing several new entities within Johnson & Johnson and was involved in setting up the Scripps/J&J collaborative effort, and headed the original J&J division established to develop technology emanating from Scripps. Dr. Tripodi holds a PhD in Immunochemistry from Temple University. He has published extensively in the fields of immunochemistry and immunology, and holds several patents, for both drugs and devices.
Director of Operations
Mr. Morris has more than 20 years’ experience in the development and manufacturing of biologically active protein complexes including Cyplexinol®, both in the oral and surgical grade forms. Mr. Morris’ experiences include; R&D technology transfer, product development as well as production launch implementation. Mr. Morris worked with Dr. Nelson Scarborough, pioneering and developing many of the surgical forms of Cyplexinol® used today by orthopedic surgeons for bone and cartilage growth. Mr. Morris has written and been awarded 14 patents for; orthopedic and spinal implant products, instrumentation development, and processes flow design. Mr. Morris received his Professional Management Certificate from the American Management Association.
Scientific and Medical Advisory Panel
WILLIAM FRANKE, PHD
Dr. Franke has twenty-eight years of senior management experience at Unilever. He was Vice President for R&D, Quality and Regulatory Affairs at Unilever’s Lipton division. He then served as Vice President for Scientific and Regulatory Affairs, reporting to the President, CEO and Chairman, and was responsible for nutritional science for all of Unilever’s United State businesses. Dr. Franke founded Heart Blend Foods, LLC, a research and development company that specializes in the development of heart-healthy foods. Dr. Franke is Associate Director of the Center for Advanced Foods at Rutgers University and is an expert in the area of product development and food regulations, especially as it related to functional foods and nutraceuticals.
RICHARD GARIAN, DC
Dr. Garian is a Certified Chiropractic Sports Physician (CCSP) in Massachusetts, with 30 years of clinical and scientific research experience. Dr. Garian’s experience includes post-graduate studies in the field of biochemistry at the University of New Hampshire, nutritional studies at the Harvard School of Public Health and over 300 hours in chiropractic orthopedics. Dr. Garian is a founding fellow of the American Back Society and a founding member of the Spine Managed Care.
ADAM PERLMAN, MD
Dr. Adam Perlman is a medical doctor, who was recently appointed to the position of Executive Director of Duke Integrative Medicine in September 2011. In 2010 he became the Chair for the Consortium of Academic Health Centers for Integrative Medicine, a consortium comprising 50 leading academic medical centers around the country with integrative medical programs. Since 2007, Dr. Perlman has been Chairperson for the Department of Primary Care within the School of Health Related Professions at University of Medicine and Dentistry of New Jersey (UMDNJ). He has held the UMDNJ Hunterdon Endowed Professorship in Complementary and Alternative Medicine since 2004.
NELSON SCARBOROUGH, PHD
Dr. Scarborough has extensive experience in the development of orthobiologic products for bone and soft tissue repair. Dr Scarborough was a pioneer in the development of BMP-complex products for surgery before becoming the director of advanced research at Covidien. He earned his PhD in Pharmacology at the Medical College of Georgia and a Bachelor of Science in Biology and Chemistry at Furman University.
JIM POSER, PHD
Dr. Poser holds a Doctorate in Chemistry from the University of California San Diego and a Bachelor of Science degree in Biochemistry and Molecular Biology from University of California Santa Barbara. He is a published expert in the field of osteobiologics with over 20 years of experience in research of bone diagnostics and osteobiologics for skeletal repair. He is the inventor on 9 patents and author on over 40 peer reviewed publications. Dr. Poser has held numerous senior clinical and R&D positions in the industry, including Osteotech, Inc. – the pioneers in osteobiologics, and Procter & Gamble Inc. where he worked directly on their bone research/bisphosphonate project.
LUKE BUCCI, PHD
Dr. Bucci holds a PhD in Biomedical Sciences (Biochemistry and Cell Biology), from the University of Texas Health Science Center. He previously was the Research Director for Biotics Research Corp. and then served as the first Director of Science and Quality at SpectraCell Laboratories Inc. Dr. Bucci was Vice President, Research for Weider/Schiff Nutrition for over 17 years, and Research & Scientific Affairs Specialist for Schiff Nutrition after its acquisition by Reckitt Benckiser in 2013.